Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer.

Henke A, Grace OC, Ashley GR, Stewart GD, Riddick AC, Yeun H, O'Donnell M, Anderson RA, Thomson AA.

PLoS One. 2012;7(8):e42516. doi: 10.1371/journal.pone.0042516. Epub 2012 Aug 3.

2.

Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Gregg JL, Brown KE, Mintz EM, Piontkivska H, Fraizer GC.

BMC Cancer. 2010 Apr 28;10:165. doi: 10.1186/1471-2407-10-165.

3.

Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.

Orr B, Riddick AC, Stewart GD, Anderson RA, Franco OE, Hayward SW, Thomson AA.

Oncogene. 2012 Mar 1;31(9):1130-42. doi: 10.1038/onc.2011.312. Epub 2011 Aug 1.

4.

Identification of EphrinB1 expression in prostatic mesenchyme and a role for EphB-EphrinB signalling in prostate development.

Ashley GR, Grace OC, Vanpoucke G, Thomson AA.

Differentiation. 2010 Sep-Oct;80(2-3):89-98. doi: 10.1016/j.diff.2010.06.003. Epub 2010 Jul 15.

PMID:
20633976
5.

The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.

Said N, Frierson HF Jr, Chernauskas D, Conaway M, Motamed K, Theodorescu D.

Oncogene. 2009 Oct 1;28(39):3487-98. doi: 10.1038/onc.2009.205. Epub 2009 Jul 13.

PMID:
19597474
6.
7.

Differential expression of osteonectin/SPARC during human prostate cancer progression.

Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL.

Clin Cancer Res. 2000 Mar;6(3):1140-9.

8.

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.

Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M.

Oncogene. 2003 Aug 7;22(32):5021-30.

PMID:
12902985
9.

Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.

Brown TJ, Shaw PA, Karp X, Huynh MH, Begley H, Ringuette MJ.

Gynecol Oncol. 1999 Oct;75(1):25-33.

PMID:
10502421
10.

Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast.

Boström P, Sainio A, Kakko T, Savontaus M, Söderström M, Järveläinen H.

Histochem Cell Biol. 2013 Jan;139(1):161-71. doi: 10.1007/s00418-012-1026-0. Epub 2012 Sep 25.

11.

Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.

Joesting MS, Perrin S, Elenbaas B, Fawell SE, Rubin JS, Franco OE, Hayward SW, Cunha GR, Marker PC.

Cancer Res. 2005 Nov 15;65(22):10423-30.

12.

Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease.

Vanpoucke G, Orr B, Grace OC, Chan R, Ashley GR, Williams K, Franco OE, Hayward SW, Thomson AA.

Genome Biol. 2007;8(10):R213.

13.

Role of stroma in carcinogenesis of the prostate.

Cunha GR, Hayward SW, Wang YZ.

Differentiation. 2002 Dec;70(9-10):473-85. Review.

PMID:
12492490
14.

A role for notch signaling in stromal survival and differentiation during prostate development.

Orr B, Grace OC, Vanpoucke G, Ashley GR, Thomson AA.

Endocrinology. 2009 Jan;150(1):463-72. doi: 10.1210/en.2008-0383. Epub 2008 Sep 18.

PMID:
18801907
15.

Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.

Elo TD, Valve EM, Seppänen JA, Vuorikoski HJ, Mäkelä SI, Poutanen M, Kujala PM, Härkönen PL.

Neoplasia. 2010 Nov;12(11):915-27.

16.

Developmental regulation of decorin expression in postnatal rat brain.

Kappler J, Stichel CC, Gleichmann M, Gillen C, Junghans U, Kresse H, Müller HW.

Brain Res. 1998 May 18;793(1-2):328-32.

PMID:
9630708
17.

Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.

Yoshimura T, Nagahara M, Kuo C, Turner RR, Soon-Shiong P, Hoon DS.

Epigenetics. 2011 Aug;6(8):1001-11. doi: 10.4161/epi.6.8.16063. Epub 2011 Aug 1.

PMID:
21725199
18.

DNA methylation and aberrant expression of Sprouty1 in human prostate cancer.

Kwabi-Addo B, Ren C, Ittmann M.

Epigenetics. 2009 Jan;4(1):54-61. Epub 2009 Jan 20.

PMID:
19164898
19.

The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.

Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M.

Cancer Res. 2004 Jul 15;64(14):4728-35.

20.

Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.

Watkins G, Douglas-Jones A, Bryce R, Mansel RE, Jiang WG.

Prostaglandins Leukot Essent Fatty Acids. 2005 Apr;72(4):267-72.

PMID:
15763438

Supplemental Content

Support Center